169 related articles for article (PubMed ID: 18813118)
1. Undifferentiated carcinoma with osteoclastic giant cells (UCOCGC) of the pancreas associated with the familial atypical multiple mole melanoma syndrome (FAMMM).
Koorstra JB; Maitra A; Morsink FH; Drillenburg P; ten Kate FJ; Hruban RH; Offerhaus JA
Am J Surg Pathol; 2008 Dec; 32(12):1905-9. PubMed ID: 18813118
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer-associated gene polymorphisms in a nation-wide cohort of p16-Leiden germline mutation carriers; a case-control study.
Potjer TP; van der Stoep N; Houwing-Duistermaat JJ; Konings IC; Aalfs CM; van den Akker PC; Ausems MG; Dommering CJ; van der Kolk LE; Maiburg MC; Spruijt L; Wagner A; Vasen HF; Hes FJ
BMC Res Notes; 2015 Jun; 8():264. PubMed ID: 26111702
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.
Lynch HT; Brand RE; Hogg D; Deters CA; Fusaro RM; Lynch JF; Liu L; Knezetic J; Lassam NJ; Goggins M; Kern S
Cancer; 2002 Jan; 94(1):84-96. PubMed ID: 11815963
[TBL] [Abstract][Full Text] [Related]
4. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden).
Vasen HF; Gruis NA; Frants RR; van Der Velden PA; Hille ET; Bergman W
Int J Cancer; 2000 Sep; 87(6):809-11. PubMed ID: 10956390
[TBL] [Abstract][Full Text] [Related]
5. Head and neck squamous cell carcinoma in FAMMM syndrome.
Vinarsky V; Fine RL; Assaad A; Qian Y; Chabot JA; Su GH; Frucht H
Head Neck; 2009 Nov; 31(11):1524-7. PubMed ID: 19360740
[TBL] [Abstract][Full Text] [Related]
6. Well-differentiated Pancreatic Neuroendocrine Tumor in a Patient With Familial Atypical Multiple Mole Melanoma Syndrome (FAMMM).
Noƫ M; Hackeng WM; de Leng WWJ; Vergeer M; Vleggaar FP; Morsink FHM; Wood LD; Hruban RH; Offerhaus GJA; Brosens LAA
Am J Surg Pathol; 2019 Sep; 43(9):1297-1302. PubMed ID: 31261289
[TBL] [Abstract][Full Text] [Related]
7. Development of esophageal squamous cell cancer in patients with FAMMM syndrome: Two clinical reports.
van der Wilk BJ; Noordman BJ; Atmodimedjo PN; Dinjens WNM; Laheij RJF; Wagner A; Wijnhoven BPL; van Lanschot JJB
Eur J Med Genet; 2020 Mar; 63(3):103840. PubMed ID: 31923587
[TBL] [Abstract][Full Text] [Related]
8. [From gene to disease; from p16 to melanoma].
Gruis NA; Bergman W
Ned Tijdschr Geneeskd; 2000 Oct; 144(44):2100-2. PubMed ID: 11103670
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the
Middlebrooks CD; Stacey ML; Li Q; Snyder C; Shaw TG; Richardson-Nelson T; Rendell M; Ferguson C; Silberstein P; Casey MJ; Bailey-Wilson JE; Lynch HT
Cancer Res; 2019 Jun; 79(11):2992-3000. PubMed ID: 30967399
[TBL] [Abstract][Full Text] [Related]
10. A locus linked to p16 modifies melanoma risk in Dutch familial atypical multiple mole melanoma (FAMMM) syndrome families.
van der Velden PA; Sandkuijl LA; Bergman W; Hille ET; Frants RR; Gruis NA
Genome Res; 1999 Jun; 9(6):575-80. PubMed ID: 10400925
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the neoplastic phenotype in the familial atypical multiple-mole melanoma-pancreatic carcinoma syndrome.
Rulyak SJ; Brentnall TA; Lynch HT; Austin MA
Cancer; 2003 Aug; 98(4):798-804. PubMed ID: 12910525
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-leiden).
de vos tot Nederveen Cappel WH; Offerhaus GJ; van Puijenbroek M; Caspers E; Gruis NA; De Snoo FA; Lamers CB; Griffioen G; Bergman W; Vasen HF; Morreau H
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3598-605. PubMed ID: 14506146
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer and the familial atypical multiple mole melanoma (FAMMM) syndrome.
Lynch HT; Fusaro RM
Pancreas; 1991 Mar; 6(2):127-31. PubMed ID: 1886881
[TBL] [Abstract][Full Text] [Related]
14. Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance.
Kluijt I; Cats A; Fockens P; Nio Y; Gouma DJ; Bruno MJ
J Clin Gastroenterol; 2009 Oct; 43(9):853-7. PubMed ID: 19417680
[TBL] [Abstract][Full Text] [Related]
15. [Biallelic inactivation of the p16-Gen in a metachronous triple carcinoma in the oropharyngeal region].
Motsch C; Giers A; Boltze C; Evert M; Freigang B; Roessner A; Schneider-Stock R
Laryngorhinootologie; 2004 Jan; 83(1):55-60. PubMed ID: 14740307
[TBL] [Abstract][Full Text] [Related]
16. Update on familial pancreatic cancer.
Lynch HT; Brand RE; Deters CA; Fusaro RM
Curr Gastroenterol Rep; 2001 Apr; 3(2):121-8. PubMed ID: 11276379
[TBL] [Abstract][Full Text] [Related]
17. Familial atypical multiple mole melanoma (FAMMM) syndrome: history, genetics, and heterogeneity.
Lynch HT; Shaw TG
Fam Cancer; 2016 Jul; 15(3):487-91. PubMed ID: 26892865
[TBL] [Abstract][Full Text] [Related]
18. Loss of Wild-Type CDKN2A Is an Early Event in the Development of Melanoma in FAMMM Syndrome.
Christodoulou E; Nell RJ; Verdijk RM; Gruis NA; van der Velden PA; van Doorn R
J Invest Dermatol; 2020 Nov; 140(11):2298-2301.e3. PubMed ID: 32234459
[No Abstract] [Full Text] [Related]
19. Pancreatic cancer and the FAMMM syndrome.
Lynch HT; Fusaro RM; Lynch JF; Brand R
Fam Cancer; 2008; 7(1):103-12. PubMed ID: 17992582
[TBL] [Abstract][Full Text] [Related]
20. Familial pancreatic carcinoma in Jews.
Lynch HT; Deters CA; Lynch JF; Brand RE
Fam Cancer; 2004; 3(3-4):233-40. PubMed ID: 15516847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]